These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
431 related articles for article (PubMed ID: 23722018)
21. Gastrointestinal stromal tumors (GISTs): definition, occurrence, pathology, differential diagnosis and molecular genetics. Miettinen M; Lasota J Pol J Pathol; 2003; 54(1):3-24. PubMed ID: 12817876 [TBL] [Abstract][Full Text] [Related]
22. [CD117 contribution in the diagnosic of mesenchymal tumors of the digestive tract]. Khadija B; Saadia B; Ines C; Sami K; Mohamed J; Zina C; Nidhammeddine K; Mohamed MZ; Slim H Tunis Med; 2005 Nov; 83(11):669-71. PubMed ID: 16422363 [TBL] [Abstract][Full Text] [Related]
23. DOG1 for the diagnosis of gastrointestinal stromal tumor (GIST): Comparison between 2 different antibodies. Lopes LF; West RB; Bacchi LM; van de Rijn M; Bacchi CE Appl Immunohistochem Mol Morphol; 2010 Jul; 18(4):333-7. PubMed ID: 20571340 [TBL] [Abstract][Full Text] [Related]
24. The utility of discovered on gastrointestinal stromal tumor 1 (DOG1) antibody in surgical pathology-the GIST of it. Lee CH; Liang CW; Espinosa I Adv Anat Pathol; 2010 May; 17(3):222-32. PubMed ID: 20418677 [TBL] [Abstract][Full Text] [Related]
25. Diagnostic relevance of overexpressions of PKC-θ and DOG-1 and KIT/PDGFRA gene mutations in extragastrointestinal stromal tumors: a Korean six-centers study of 28 cases. Kim KH; Nelson SD; Kim DH; Choi KU; Kim SJ; Min KW; Jang KS; Paik SS; Oh YH; Chae SW; Sohn JH; Kim HJ; Cho YK; Kim BI; Park DI; Sohn CI; Oh S; Choi SH; Choi YJ; Woo HY; Park YL; Park SJ; Lee SH; Ryu S; DO SI; Kang G; Kim K; Cho YH; Pyo JS Anticancer Res; 2012 Mar; 32(3):923-37. PubMed ID: 22399613 [TBL] [Abstract][Full Text] [Related]
26. Expression of DOG1, CD117 and PDGFRA in gastrointestinal stromal tumors and correlations with clinicopathology. Sui XL; Wang H; Sun XW Asian Pac J Cancer Prev; 2012; 13(4):1389-93. PubMed ID: 22799337 [TBL] [Abstract][Full Text] [Related]
27. Correlation of immunophenotype with progression-free survival in patients with gastrointestinal stromal tumors treated with imatinib mesylate. Chirieac LR; Trent JC; Steinert DM; Choi H; Yang Y; Zhang J; Patel SR; Benjamin RS; Raymond AK Cancer; 2006 Nov; 107(9):2237-44. PubMed ID: 16998931 [TBL] [Abstract][Full Text] [Related]
28. Analysis of mutation and expression of c-kit and PDGFR-alpha gene in gastrointestinal stromal tumor. Zheng S; Chen LR; Wang HJ; Chen SZ Hepatogastroenterology; 2007 Dec; 54(80):2285-90. PubMed ID: 18265649 [TBL] [Abstract][Full Text] [Related]
29. GIST Manifesting as a Retroperitoneal Tumor: Clinicopathologic Immunohistochemical, and Molecular Genetic Study of 112 Cases. Miettinen M; Felisiak-Golabek A; Wang Z; Inaguma S; Lasota J Am J Surg Pathol; 2017 May; 41(5):577-585. PubMed ID: 28288036 [TBL] [Abstract][Full Text] [Related]
30. [Gastrointestinal stromal tumors (GISTs): clinical and pathological features]. Kovács M; Nagy P; Pák G; Fehér J Orv Hetil; 2005 Jun; 146(26):1375-81. PubMed ID: 16052979 [TBL] [Abstract][Full Text] [Related]
31. Old and new immunohistochemical markers for the diagnosis of gastrointestinal stromal tumors. González-Cámpora R; Delgado MD; Amate AH; Gallardo SP; León MS; Beltrán AL Anal Quant Cytol Histol; 2011 Feb; 33(1):1-11. PubMed ID: 22125840 [TBL] [Abstract][Full Text] [Related]
32. Gastrointestinal stromal tumors presenting as omental masses--a clinicopathologic analysis of 95 cases. Miettinen M; Sobin LH; Lasota J Am J Surg Pathol; 2009 Sep; 33(9):1267-75. PubMed ID: 19440146 [TBL] [Abstract][Full Text] [Related]
33. DOG1 antibody is a highly sensitive and specific marker for gastrointestinal stromal tumors in cytology cell blocks. Hwang DG; Qian X; Hornick JL Am J Clin Pathol; 2011 Mar; 135(3):448-53. PubMed ID: 21350101 [TBL] [Abstract][Full Text] [Related]
34. Gastrointestinal stromal tumours (GISTs) negative for KIT (CD117 antigen) immunoreactivity. Debiec-Rychter M; Wasag B; Stul M; De Wever I; Van Oosterom A; Hagemeijer A; Sciot R J Pathol; 2004 Apr; 202(4):430-8. PubMed ID: 15095270 [TBL] [Abstract][Full Text] [Related]
35. Clinicopathologic study of 275 cases of gastrointestinal stromal tumors: the experience at 3 large medical centers in Mexico. Alvarado-Cabrero I; Vázquez G; Sierra Santiesteban FI; Hernández-Hernández DM; Pompa AZ Ann Diagn Pathol; 2007 Feb; 11(1):39-45. PubMed ID: 17240306 [TBL] [Abstract][Full Text] [Related]
36. [Expression and gene mutation of phospho-platelet derived growth factor receptor alpha and C-kit in gastrointestinal and extra-gastrointestinal stromal tumors]. Tang M; Li DQ Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Jan; 11(1):80-3. PubMed ID: 18197502 [TBL] [Abstract][Full Text] [Related]
39. PDGFRA and KIT Mutation Status and Its Association With Clinicopathological Properties, Including DOG1. Baskin Y; Kocal GC; Kucukzeybek BB; Akbarpour M; Kayacik N; Sagol O; Ellidokuz H; Oztop I Oncol Res; 2016; 24(1):41-53. PubMed ID: 27178821 [TBL] [Abstract][Full Text] [Related]
40. PDGFR expression in differential diagnosis between KIT-negative gastrointestinal stromal tumours and other primary soft-tissue tumours of the gastrointestinal tract. Rossi G; Valli R; Bertolini F; Marchioni A; Cavazza A; Mucciarini C; Migaldi M; Federico M; Trentini GP; Sgambato A Histopathology; 2005 May; 46(5):522-31. PubMed ID: 15842634 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]